OTC Medicines

CHPA released the following statement in response to the CDC Viewpoints article titled, “Prevention of Unintentional Medication Overdose Among Children,” published in the Journal of the American Medical Association.

The results of nearly all recent observational studies of patients from around the world diagnosed with COVID-19 show no association between exposure to NSAIDs (including ibuprofen) and worsening clinical outcomes.

What follows is a timeline for implementation of OTC monograph reform under HR 748, also known as the CARES Act.

CHPA is rebranding its identity for the first time in 20 years. The rebranding effort has resulted in a new logo, tagline, and brand narrative following the addition of consumer medical devices to its scope of representation.